Evaluating the feasibility of a primary care-based treatment for restrictive eating disorders in children and adolescents

评估针对儿童和青少年限制性饮食失调的初级保健治疗的可行性

基本信息

  • 批准号:
    10569776
  • 负责人:
  • 金额:
    $ 23.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-15 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT In the United States, half a million adolescents suffer from an eating disorder. With only 66 certified providers nationally, Family-Based Treatment (FBT), a first-line evidence-based treatment for adolescent eating disorders, is not readily available to most families. This provider shortage leaves most young patients without care and undoubtedly contributes to the chronicity and lethality of these conditions. Patients with eating disorders generally make their first contact with the healthcare system in primary care. As such, equipping primary care providers (PCPs) with effective means to treat these patients has potential to democratize care, improve rates of early intervention, and enhance patient outcomes. Family-Based Treatment for Primary Care (FBT-PC) is a novel intervention for delivery by a PCP in primary care that uses FBT strategies. Data support proof-of-concept for this adaptation. We have several study aims. (1) We will finalize the FB-PC intervention through an open case series. (2) We will establish the feasibility and acceptability of FBT-PC for caregivers, patients, and PCPs in a pilot randomized controlled trial. Finally, (3) we will test preliminary target engagement of FBT-PC and determine whether it is associated with improved caregiver self-efficacy and, through this mechanism, symptom remission. Remission will be defined as weight restoration to 95% of expected body weight and a score within 1 SD of community norms on the Eating Disorder Examination-Questionnaire. We also propose (4) an exploratory aim to evaluate baseline characteristics of our sample to determine for whom the FBT-PC intervention is most beneficial. To accomplish all aims we will complete an open case series (n = 6), followed by a pilot trial in which we will randomly assign 40 patients (ages 7-18 years) with restrictive eating disorders and their caregiver(s) to FBT-PC or a control condition of standard FBT. Families will attend up to 18 sessions over 6 months. Goals from the open case series (Aim 1) will include the development of tools for FBT-PC training and implementation, including treatment and training protocols and fidelity measures. Feasibility (Aim 2) will be assessed through an evaluation of recruitment and retention. Acceptability (Aim 2) will be evaluated using mixed methods surveys and interviews of caregivers, patients and PCPs on the topics of tolerability, fit, and burden. We will also assess the degree to which FBT-PC engages our proposed mechanism of change, caregiver self-efficacy, to facilitate symptom remission (Aim 3). Effect sizes will be calculated for FBT-PC with a goal of ≥ 0.5, comparable with those found in FBT trials. Finally, baseline sample characteristics (Exploratory Aim) will be assessed including caregiver perceptions about their child’s illness, referral method, length of illness, and symptom severity. Once we have established feasibility, acceptability, and target engagement of the FBT-PC intervention, we intend to use these findings in support of a large pragmatic clinical trial to evaluate the noninferiority of effectiveness of FBT-PC versus standard FBT.
抽象的 在美国,有50万青少年患有饮食失调症。只有66个认证提供商 全国性的基于家庭的治疗(FBT),这是一种基于一线证据的青少年饮食 大多数家庭不容易获得疾病。这个提供者的短缺使大多数年轻患者没有 护理和无疑有助于这些疾病的慢性和致命性。饮食患者 疾病通常是与初级保健中医疗系统的首次接触。因此,装备 具有有效治疗这些患者的有效手段的初级保健提供者(PCP)有可能使护理民主化, 提高早期干预的速度,并提高患者预后。基于家庭的初级保健治疗 (FBT-PC)是一种新的干预措施,用于使用FBT策略的PCP在初级保健中提供。数据支持 这种适应的概念证明。我们有一些研究目标。 (1)我们将最终确定FB-PC干预 通过一个开放式案例系列。 (2)我们将确定FBT-PC对护理人员的可行性和可接受性, 患者和PCP在试验中随机对照试验中。最后,(3)我们将测试初步目标参与 FBT-PC并确定它是否与改善的护理人员相关,并通过此 机制,症状缓解。缓解将定义为重量恢复到预期身体的95% 体重和在饮食失调检查问卷的社区规范的1个SD之内。我们 也建议(4)探索性目的是评估样本的基线特征,以确定谁 FBT-PC干预是最有益的。为了实现所有目标,我们将完成一个开放式案例系列(n = 6),然后进行试点试验,我们将随机分配40名患者(7-18岁),并进行限制性饮食 疾病及其护理人员对FBT-PC或标准FBT的控制条件。家庭最多将参加18岁 会议超过6个月。开放式案例系列的目标(AIM 1)将包括开发工具 FBT-PC培训和实施,包括治疗和培训方案以及忠诚度测量。 可行性(AIM 2)将通过评估招聘和保留率进行评估。可接受性(目标2) 将使用混合方法调查以及对主题的护理人员,患者和PCP的访谈进行评估 耐受性,适合和伯恩。我们还将评估FBT-PC参与我们建议的程度 变化的机制,护理人员的自我效能感,促进符号缓解(AIM 3)。效应尺寸将是 针对FBT-PC计算的目标≥0.5,与FBT试验中的目标相当。最后,基线样本 将评估特征(探索目的),包括照顾者对孩子病的看法, 转诊方法,疾病长度和症状严重程度。一旦我们确定了可行性,可接受性, 以及FBT-PC干预的目标参与,我们打算使用这些发现来支持大型 务实的临床试验评估了FBT-PC与标准FBT有效性的非效率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

相似国自然基金

大气污染物对青少年心理健康的影响机制研究
  • 批准号:
    42377437
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
  • 批准号:
    82373595
  • 批准年份:
    2023
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
  • 批准号:
    32300894
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
miR-125b-1-3p介导童年期不良经历影响青少年自伤行为易感性的队列研究
  • 批准号:
    82373596
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
青春期发育对青少年心理行为发展的影响及生理机制
  • 批准号:
    32300888
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
    $ 23.85万
  • 项目类别:
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
  • 批准号:
    10761853
    10761853
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
    $ 23.85万
  • 项目类别:
Understand and mitigating the influence of extreme weather events on HIV outcomes: A global investigation
了解并减轻极端天气事件对艾滋病毒感染结果的影响:一项全球调查
  • 批准号:
    10762607
    10762607
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
    $ 23.85万
  • 项目类别:
Anxiety in Youth with Autism Spectrum Disorder
自闭症谱系障碍青少年的焦虑
  • 批准号:
    10784337
    10784337
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
    $ 23.85万
  • 项目类别:
Neuromelanin MRI: A tool for non-invasive investigation of dopaminergic abnormalities in adolescent substance use.
神经黑色素 MRI:一种用于非侵入性调查青少年物质使用中多巴胺能异常的工具。
  • 批准号:
    10735465
    10735465
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
    $ 23.85万
  • 项目类别: